Page last updated: 2024-08-26

bosentan anhydrous and Fetal Growth Retardation

bosentan anhydrous has been researched along with Fetal Growth Retardation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Israël-Biet, D; Lerolle, U; Marié, E; Meyer, G; Sanchez, O; Wermert, D	1

Reviews

1 review(s) available for bosentan anhydrous and Fetal Growth Retardation

Article	Year
Pulmonary arterial hypertension in women. Revue des maladies respiratoires, 2010, Volume: 27, Issue:8 Topics: Abortion, Therapeutic; Adult; Anticoagulants; Bone Morphogenetic Protein Receptors, Type II; Bosentan; Calcium Channel Blockers; Contraception; Dyspnea; Endothelin A Receptor Antagonists; Female; Fetal Growth Retardation; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Middle Aged; Phosphodiesterase Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Preimplantation Diagnosis; Prognosis; Prostaglandins I; Sex Distribution; Sulfonamides; Ultrasonography	2010

Article

Year

Pulmonary arterial hypertension in women.

Revue des maladies respiratoires, 2010, Volume: 27, Issue:8

Topics: Abortion, Therapeutic; Adult; Anticoagulants; Bone Morphogenetic Protein Receptors, Type II; Bosentan; Calcium Channel Blockers; Contraception; Dyspnea; Endothelin A Receptor Antagonists; Female; Fetal Growth Retardation; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Middle Aged; Phosphodiesterase Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Preimplantation Diagnosis; Prognosis; Prostaglandins I; Sex Distribution; Sulfonamides; Ultrasonography

2010